Conditions: Intraocular Pressure
Keywords: IOP lowering efficacy and safety of Azopt plus Travatan
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 37
Healthy volunteers: no

Brief summary:
To evaluate the IOP (Intraocular Pressure) lowering efficacy and safety of Brinzolamide 1.0% (Azopt), dosed twice daily as adjunctive therapy in patients treated with Travoprost 0.004% (Travatan) once daily. The study is double masked. The patients will receive either treatment for 12 weeks.

Detailed description:

Arms:
arm 1: Travoprost 0.004% (once daily) + Brinzolamide 1.0% (twice daily) arm 2: Travoprost 0.004% (once daily) + Tears Naturale (twice daily)

Interventions: intervention 1: Travoprost 0.004% + Brinzolamide 1.0% intervention 2: Travoprost 0.004% + Tears Natural
Intervention descriptions: intervention 1: Travoprost 0.004% (once daily) + Brinzolamide 1.0% (twice daily) intervention 2: Travoprost 0.004% (once daily) + Tears Naturale (twice daily)

Protocol document: